Literature DB >> 12124171

Focus on acute leukemias.

D Gary Gilliland1, Martin S Tallman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12124171     DOI： 10.1016/s1535-6108(02)00081-8

Source DB:  PubMed          Journal:  Cancer Cell        ISSN： 1535-6108            Impact factor:   31.743


× No keyword cloud information.
  57 in total

1.  Retroviral vector insertion sites associated with dominant hematopoietic clones mark "stemness" pathways.

Authors:  Olga S Kustikova; Hartmut Geiger; Zhixiong Li; Martijn H Brugman; Stuart M Chambers; Chad A Shaw; Karin Pike-Overzet; Dick de Ridder; Frank J T Staal; Gottfried von Keudell; Kerstin Cornils; Kalpana Jekumar Nattamai; Ute Modlich; Gerard Wagemaker; Margaret A Goodell; Boris Fehse; Christopher Baum
Journal:  Blood       Date:  2006-11-21       Impact factor: 22.113

Review 2.  Chromosomal translocations involving the MLL gene: molecular mechanisms.

Authors:  Peter D Aplan
Journal:  DNA Repair (Amst)       Date:  2006-06-21

3.  Cytogenetic analysis in childhood acute lymphoblastic leukemia: experience at a single institution in Korea.

Authors:  Young Joo Kwon; Jae Wook Lee; Myung Shin Kim; Pil Sang Jang; Nak Gyun Chung; Dae Chul Jeong; Yong Goo Kim; Kyung Ja Han; Soon Ju Lee; Bin Cho; Hack Ki Kim
Journal:  Int J Hematol       Date:  2008-12-25       Impact factor: 2.490

4.  Structural basis for recognition of SMRT/N-CoR by the MYND domain and its contribution to AML1/ETO's activity.

Authors:  Yizhou Liu; Wei Chen; Justin Gaudet; Matthew D Cheney; Liya Roudaia; Tomasz Cierpicki; Rachel C Klet; Kari Hartman; Thomas M Laue; Nancy A Speck; John H Bushweller
Journal:  Cancer Cell       Date:  2007-06       Impact factor: 31.743

5.  Retroviral insertional mutagenesis can contribute to immortalization of mature T lymphocytes.

Authors:  Sebastian Newrzela; Kerstin Cornils; Tim Heinrich; Julia Schläger; Ji-Hee Yi; Olga Lysenko; Janine Kimpel; Boris Fehse; Dorothee von Laer
Journal:  Mol Med       Date:  2011-07-27       Impact factor: 6.354

6.  Dual mTORC2/mTORC1 targeting results in potent suppressive effects on acute myeloid leukemia (AML) progenitors.

Authors:  Jessica K Altman; Antonella Sassano; Surinder Kaur; Heather Glaser; Barbara Kroczynska; Amanda J Redig; Suzanne Russo; Sharon Barr; Leonidas C Platanias
Journal:  Clin Cancer Res       Date:  2011-03-17       Impact factor: 12.531

7.  The fusion partner specifies the oncogenic potential of NUP98 fusion proteins.

Authors:  Jesslyn Saw; David J Curtis; Damian J Hussey; Alexander Dobrovic; Peter D Aplan; Christopher I Slape
Journal:  Leuk Res       Date:  2013-09-21       Impact factor: 3.156

8.  Leukemic transformation in mice expressing a NUP98-HOXD13 transgene is accompanied by spontaneous mutations in Nras, Kras, and Cbl.

Authors:  Christopher Slape; Leah Y Liu; Sarah Beachy; Peter D Aplan
Journal:  Blood       Date:  2008-06-19       Impact factor: 22.113

9.  The immune receptor Trem1 cooperates with diminished DNA damage response to induce preleukemic stem cell expansion.

Authors:  W Du; S Amarachintha; A Wilson; Q Pang
Journal:  Leukemia       Date:  2016-08-29       Impact factor: 11.528

10.  Gain of MYC underlies recurrent trisomy of the MYC chromosome in acute promyelocytic leukemia.

Authors:  Letetia Jones; Guangwei Wei; Sabina Sevcikova; Vernon Phan; Sachi Jain; Angell Shieh; Jasmine C Y Wong; Min Li; Joshua Dubansky; Mei Lin Maunakea; Rachel Ochoa; George Zhu; Thelma R Tennant; Kevin M Shannon; Scott W Lowe; Michelle M Le Beau; Scott C Kogan
Journal:  J Exp Med       Date:  2010-11-08       Impact factor: 14.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.